 |
|
|
| |
Sofosbuvir + Glecaprevir/Pibrentasvir (G/P) in patients with difficult to treat HCV infection. Final results of the French compassionate use
|
| |
| |
Reported by Jules Levin
DDW 2018 June 2-5 Wash DC
Victor de Ledinghen, Anne Varaut, Jose Ursic-Bedoya, Lucia Parlati, Jean-Baptiste Hiriart, Giovanna Scoazec, Wassil Merrouche, Georges-Philippe Pageaux, Helene Fontaine, Laurent Alric, Christophe Hezode
|
| |
|
|
|
|
|
